Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04606316
Title Surgical Nivolumab And Ipilimumab For Recurrent GBM
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Patrick Y. Wen, MD
Indications

glioblastoma

high grade glioma

gliosarcoma

Therapies

Nivolumab

Ipilimumab + Nivolumab

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST